Model
Edge
Alnylam Pharmaceuticals, Inc.
0001446125
Filing Type
4
Filing Date
6/2/2025
Updated
6/3/25, 2:10 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership